ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)

Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 19 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics

Intellia Therapeutics Opened at 9.03 and Closed at: 9.25, which is 4% of previous session's close. It moved within a range of 8.90 and 9.54
The session was a Bullish session with an average volume of 2804755, which is -19.69% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.

Support for tomorrow is 9.08 and resistance for tomorrow is 9.72
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 8.92, 8.59 resistance for tomorrow's hourly charts is 9.56, 9.87

10 Day SMA for Intellia Therapeutics (NTLA) is 9.19 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Intellia Therapeutics (NTLA) is 8.97 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Intellia Therapeutics (NTLA) is 13.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 13.51 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Intellia Therapeutics is 11.28 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Intellia Therapeutics is at 8.97 and 200 DMA is at 11.28, while 50 DMA and 100 DMA are at 13.31 and 13.51 respectively

Intellia Therapeutics (NTLA) moving average of 20 SMA is at 8.97 and 20 EMA is at 9.45

Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.31 and 50 EMA is at 11.4

Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.51 and 100 EMA is at 12.37

Intellia Therapeutics (NTLA) moving average of 200 SMA is at 11.28 and 200 EMA is at 12.95

Intellia Therapeutics has performed better than United Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Trinity Biotech in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Sanofi in short term. Holding Intellia Therapeutics could be a better choice for now!

Pulse Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Pulse Biosciences, about 4.62% more returns!

Endra Life has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Endra Life, about 7.33% more returns!

Intellia Therapeutics has performed better than Merit Medical in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Medpace Holdings in short term. Holding Intellia Therapeutics could be a better choice for now!

Moleculin Biotech has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 794.31% more returns!

Kodiak Sciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Kodiak Sciences, about 12.37% more returns!

Intellia Therapeutics has performed better than Alkermes Plc in short term. Holding Intellia Therapeutics could be a better choice for now!

Cogentix Medical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Cogentix Medical, about 5.29% more returns!

Intellia Therapeutics has performed better than Denali Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Fonar Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Gilead Sciences in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Icu Medical in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Iterum Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics Technical analysis of indicators

Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Intellia Therapeutics in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Intellia Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 9.18 and Intellia Therapeutics NTLA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.

Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NTLA Experts View which covers a lot of information including buying and selling signals

NTLA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here

Chart Intellia Therapeutics (NTLA)  Technical (Analysis) Reports Intellia Therapeutics [

Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Intellia Therapeutics (NTLA)  Technical (Analysis) Reports Intellia Therapeutics [

 

Back to top